Biolife solutions to report third quarter 2025 financial results and business update on november 6, 2025

Bothell, wash. , oct. 23, 2025 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") market, today announced the company's third quarter 2025 financial results will be released after market close on thursday, november 6, 2025.

BLFS Ratings Summary

BLFS Quant Ranking